Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Lopinavir and ritonavir
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Kaletra 100mg/25mg tablets
0503010G0BBADAD
|
Kaletra | Lopinavir and ritonavir | Infections | No data available |
|
Kaletra 133.3mg/33.3mg capsules
0503010G0BBAAAA
|
Kaletra | Lopinavir and ritonavir | Infections | No data available |
|
Kaletra 200mg/50mg tablets
0503010G0BBACAC
|
Kaletra | Lopinavir and ritonavir | Infections | No data available |
|
Kaletra 80mg/20mg/1ml oral solution
0503010G0BBABAB
|
Kaletra | Lopinavir and ritonavir | Infections | No data available |
|
Lopinavir 100mg / Ritonavir 25mg tablets
0503010G0AAADAD
|
Lopinavir/ritonavir | Lopinavir and ritonavir | Infections | No data available |
|
Lopinavir 133.3mg / Ritonavir 33.3mg capsules
0503010G0AAAAAA
|
Lopinavir/ritonavir | Lopinavir and ritonavir | Infections | No data available |
|
Lopinavir 200mg / Ritonavir 50mg tablets
0503010G0AAACAC
|
Lopinavir/ritonavir | Lopinavir and ritonavir | Infections | No data available |
|
Lopinavir 400mg/5ml / Ritonavir 100mg/5ml oral solution
0503010G0AAABAB
|
Lopinavir/ritonavir | Lopinavir and ritonavir | Infections | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.